Could bone marrow from deceased donors cure blood cancers?
NCT ID NCT07710781
First seen Jul 17, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study tests whether bone marrow from deceased donors can be used to treat people with blood cancers like leukemia and lymphoma. Participants receive a transplant of cryopreserved marrow from a deceased donor or standard cells from a living donor. The goal is to see if the deceased-donor marrow can successfully restore healthy blood cell production.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cryopreserved bone marrow from deceased donors
- What this could lead to
- If successful, this could make bone marrow transplants available to more patients by using deceased donors, reducing wait times and expanding the donor pool.
- What could go wrong
- This is an early-stage study, and it is unknown if deceased-donor marrow will engraft as reliably as living-donor cells. Risks include graft failure, infection, and graft-versus-host disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE BIPHENOTYPIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Could a diet and exercise program help childhood leukemia survivors live healthier?
- Can a targeted drug plus donor immune cells fight back against relapsed leukemia?
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Can a Two-Drug combo outsmart a deadly leukemia?
- Can a new pill take on Hard-to-Treat leukemia?